Search results for "Anticoagulation"


 
Results 141 - 150 of about 593 for "Anticoagulation".
Sort by: Relevance | Newest | Oldest

In the News

Antibiotic therapy and sepsis, reductions in MRSA infections after surgery, and more.
https://acphospitalist.acponline.org/archives/2011/05/itn.htm
15 May 2011

Recent Research

Restrictive transfusions, hospice care use, and more.
https://acphospitalist.acponline.org/archives/2011/05/rr.htm
15 May 2011

Pulmonary embolism may be overdiagnosed in the U.S., study suggests

Use of computed tomographic pulmonary angiography (CTPA) may have led to overdiagnosis of pulmonary embolism (PE) in the U.S., according to a new study.
https://acphospitalist.acponline.org/weekly/archives/2011/05/18/4.htm
18 May 2011

Recent Research

Gait speed and cardiac surgery outcomes, bloodstream infection surveillance, and more.
https://acphospitalist.acponline.org/archives/2011/06/research.htm
15 Jun 2011

Outpatient PE treatment not inferior to inpatient management for low-risk patients

Outpatient care for pulmonary embolism (PE) can safely and effectively be used in place of inpatient care in patients with low risk of death, a new study found.
https://acphospitalist.acponline.org/weekly/archives/2011/07/13/3.htm
13 Jul 2011

In the News

Central line infection rates, organizational characteristics of hospitalist groups, and more.
https://acphospitalist.acponline.org/archives/2011/07/itn.htm
15 Jul 2011

Some additions for your med list vocabulary

Twenty-one drugs were approved by the FDA last year. An expert details which of them are most likely to matter to hospitalists.
https://acphospitalist.acponline.org/archives/2011/07/drugs.htm
15 Jul 2011

Recent Research

Urinary test to guide pneumonia treatment, stroke risk after CABG, and more.
https://acphospitalist.acponline.org/archives/2011/07/rr.htm
15 Jul 2011

Apixaban associated with more bleeding, no change in ischemic events

A phase 3 trial of apixaban, a new factor Xa inhibitor, was halted after the drug was found to increase major bleeding in patients taking it after acute coronary syndrome.
https://acphospitalist.acponline.org/weekly/archives/2011/08/03/4.htm
3 Aug 2011

Very elderly patients can benefit from well-managed vitamin K antagonist thromboprophylaxis, study suggests

Adequate management of vitamin K antagonist (VKA) therapy in trained centers allowed very old and frail patients to benefit from VKA thromboprophylaxis, an Italian study concluded.
https://acphospitalist.acponline.org/weekly/archives/2011/08/10/3.htm
10 Aug 2011

Result Page: Prev   10   11   12   13   14   15   16   17   18   19   Next